Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)
NCT00822757
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
Comparator: V710
BIOLOGICAL:
Comparator: placebo
Sponsor
Merck Sharp & Dohme LLC